On May 20, 2023, the donation signing ceremony for the "Union Friends - Baheal Pharma Group Graduate Training Program" was held at the Institute of Systems Medicine, Chinese Academy of Medical Sciences/Suzhou Institute of Systems Medicine. Baheal Pharma Group partnered with Peking Union Medical College Education Foundation to establish a ten-year donation project, totaling 5 million yuan, to support talent cultivation, scientific research innovation, and practice at the Institute of Systems Medicine, Chinese Academy of Medical Sciences.

Signing ceremony site

With the rapid development of the medical and health industry, and the increasing diverse health needs of the public, the demand for high-quality brand commercialization platform and services has surged, and higher requirements for technological innovation have been raised. High-level medical talents, as the main force of high-quality development in the pharmaceutical industry, play an important role in innovative research and development and achievement transformation. Currently, China is comprehensively strengthening the training of talents in the transformation of scientific and technological achievements in order to enhance the high-quality development of talents, further optimizing the technology transfer and transformation ecology, and accelerating “the last mile" of the transformation of scientific and technological achievements.

Vice-principal Wang Jianwei presents a donation certificate to Baheal Pharma Group

As early as in 2018, Baheal Pharma Group formed a partnership with the Suzhou Institute of Systems Medicine in the field of tumor molecular and immune diagnostics. The "Union Friends - Baheal Pharma Group Graduate Training Program" newly established by Baheal Pharma Group aims to cultivate high-level talents within the system of the Chinese Academy of Medical Sciences Institute of Systems Medicine, strengthen and improve the award system in line with the requirements of science and technology achievement transformation, promote the deep integration of industry, academia, and research, and accelerate the transformation of high-quality innovative achievements that truly serve national health and clinical needs.

Vice-principal Wang Jianwei delivers a speech

At the ceremony, Wang Jianwei, Vice President of Peking Union Medical College of the Chinese Academy of Medical Sciences, thanked Baheal Pharma Group for its donation to support medical education development and presented the company with a donation certificate. Wang Jianwei said that the Chinese Academy of Medical Sciences is the country's top research institution for medical sciences and the highest medical education institution, playing an essential role in cultivating medical talents in China and dedicates to promoting technological innovation through superior medical resources and scientific research power. He hopes that the establishment of the "Union Friends - Baheal Pharma Group Graduate Training Program" will strengthen cooperation between the two parties, making an even greater contribution to China's medical innovation talent cultivation. 

Fu Gang delivers a speech

Fu Gang, Chairman of Baheal Pharma Group, expressed that Baheal, as a health industry group driven by technological innovation, has always adhered to the corporate mission of "providing better medical and brand commercialization platform and services to society as a whole." He hopes that the establishment of this project will support the development of scientific research and education at the Chinese Academy of Medical Sciences and Peking Union Medical College, as well as the cultivation of innovative talents for medical science and technology achievements transformation. In the future, the two parties will join hands to further promote the innovative development of medical scientific research and clinical practice, and transform innovative technologies into high-quality results that can truly optimize medical scenarios.

Currently, under the strategic guidance of national science and technology innovation, the innovative achievements in the medical and health field are accelerating their implementation. Based on the development strategy of "commercial breakthroughs and ecological innovations", Baheal Pharma Group has delved into the source of innovation, established extensive and in-depth production-education-research multidimensional collaboration with national research institutes, universities, and innovative companies. The group has cultivated a series of innovative enterprises in the three tracks of innovative drugs, high-end medical devices, and technology transformation platforms, covering artificial hearts, medical linear accelerators, medical high-definition endoscopes, medical artificial intelligence, tumor and bone regeneration innovative drugs, early screening of major diseases and drug companion diagnosis, high-end controlled-release dosage forms, and other innovative fields.

Signing ceremony site

In the future, Baheal Pharma Group will continue to deepen its cooperation with national research institutes and universities, drive the transformation of scientific and technological achievements with the "talent engine", facilitate an organic connection between the "first mile" and the "last mile" of innovation, providing support to talents, and accelerate innovation.